Lacove 100mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and inhibiting repetitive neuronal firing. This mechanism helps to reduce the frequency and severity of seizures. Lacove is typically administered orally, with dosage individualized based on patient response and tolerability. It may be used as monotherapy or adjunctive therapy in adults and pediatric patients aged four years and above. Common adverse effects include dizziness, headache, nausea, and fatigue, which are generally mild to moderate in intensity. Caution is advised in patients with cardiac conduction abnormalities, as lacosamide may prolong PR interval and increase the risk of arrhythmias. Regular monitoring of cardiac function and electrocardiograms is recommended in at-risk populations. Lacove should be used with caution in patients with hepatic or renal impairment, and dose adjustments may be necessary. It is contraindicated in individuals with known hypersensitivity to lacosamide or any excipients. As with all antiepileptic drugs, abrupt discontinuation should be avoided to prevent seizure exacerbation. Lacove 100mg Tablet offers an effective therapeutic option for seizure management with a favorable safety profile when used under medical supervision.